Mereo BioPharma Group (STU:MAH0) Net Interest Margin (Bank Only) %


STU:MAH0 Mereo BioPharma Group PLC STU:MAH0
36 GF Score
Price €0.29
! 1 Warning Sign
View Full Analysis

What is Mereo BioPharma Group Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

STU:MAH0
36GF Score
Mereo BioPharma Group PLC STU:MAH0
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mereo BioPharma Group Business Description

Other Exchanges MREO:USA0A9G:UK
Address One Cavendish Place, 4th Floor, London, GBR, W1G 0QF
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
36GF Score

Get the complete analysis for STU:MAH0

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.29
Price